Steris' rating downgraded from 'buy' to 'hold' by StockNews.com despite Q4 earnings beat.
Steris, a medical equipment provider, had its rating downgraded from 'buy' to 'hold' by StockNews.com, despite beating Q4 earnings estimates by $0.05. The company reported a $2.22 EPS, 10.48% net margin, and 13.67% return on equity. Steris' stock continues to be popular among institutional investors, with 94.69% ownership. The company is scheduled to announce its Q1 2024 earnings on May 8th, with analysts expecting $2.43 EPS.
May 06, 2024
3 Articles